| 查看: 939 | 回复: 3 | |||
hdang2003木虫 (著名写手)
|
[交流]
GSK中国的中药研究部门 转自丁香园 已有3人参与
|
|
Britain’s biggest drug maker last week unveiled the outcome of a review of its 38 groups of scientists, known as Discovery Performance Units (DPU), saying it would close three units and open four. The Sunday Telegraph can reveal the new units will look at traditional Chinese medicines, investigating how their principles can be applied to making new, synthetic, molecules. “Within our discovery organisation in China we have created a DPU that will marry traditional Chinese medicine with modern drug discovery and clinical efficacy,” said Moncef Slaoui, Glaxo’s chairman of research and development. “With modern technology we have the potential to yield new molecular entities with significant efficacy.” The new unit will be based in China – Glaxo launched an R&D centre in Shanghai almost five years ago. With its pharmaceutical market forecast to mushroom to more than $100bn (?63.5bn) by 2015, China is one of the most important battlegrounds for drug companies facing pricing pressure and more competition from generics. Glaxo’s move reflects a wish by drug companies to adapt their research to particular regions. Six years ago, AstraZeneca established a centre in China to study diseases prevalent in Asia, such as liver and stomach cancer, and lung conditions. Last October, Astra also said it planned to invest $200m in a new Chinese factory making intravenous and oral solid medicines. Astra’s sales in emerging markets, including China, grew 10pc to $5.8bn last year, while Glaxo’s Asia Pacific revenues grew 7pc to ?1.8bn. 个人认为中药的前途肯定是光明的，甚至好于西药，但在过去的上千年时间里，中药的发展步伐几近停滞，是不是中药的发展得改变思路？大型药企的介入将会是个好的开端。 |
回复此楼» 本帖已获得的红花（最新10朵）
1994yw» 猜你喜欢
新版scifinder
已经有1人回复
-
安捷伦液相色谱柱与方法开发指南
已经有4人回复
-
药物学论文润色/翻译怎么收费?
已经有247人回复
-
FDA核查 研发机构
已经有1人回复
-
国家高层次人才李兴淑教授课题组招收博士研究生
已经有39人回复
-
己酮可可碱过氧化杂质限度
已经有2人回复
-
求助Isoeugenol质量标准
已经有0人回复
-
Gliclazide
已经有0人回复
-
塞替派/噻替哌（Thiotepa） 质量控制
已经有15人回复
-
有没有大佬可以帮忙查下Trijardy XR和Qternmet XR历年销售数据呀
已经有0人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 逆向恋爱术【转载】
已经有28人回复
- 中药缓释制剂研究现状
已经有8人回复
- 转化率接近100%的反应如何考察扩散对动力学的影响
已经有3人回复
- 中央民族少数民族医药研究院（985）和浙江中医药大学（普通二本），哪个更好
已经有8人回复
- 请教坐标与经纬度的转换
已经有1人回复
- 【转载】几个有道理的小故事，值得一看
已经有99人回复
- 【转帖】进口种子先免费后高价 我国种业该如何反思
已经有23人回复
1994yw
木虫 (正式写手)
- 应助: 8 (幼儿园)
- 金币: 1708.3
- 散金: 105
- 帖子: 646
- 在线: 79.5小时
- 虫号: 1242523
- 注册: 2011-03-23
- 专业: 药物设计与药物信息
2楼2012-02-21 15:19:43
weixiaogang
木虫 (正式写手)
- 应助: 24 (小学生)
- 金币: 3639.3
- 散金: 5
- 红花: 2
- 帖子: 711
- 在线: 193小时
- 虫号: 1470249
- 注册: 2011-11-01
- 性别: GG
- 专业: 药剂学
3楼2012-02-21 16:54:22
4楼2012-02-21 18:03:40